Back
HSBC Holdings PLC Vs. Aligos Therapeutics Industry Stock Comparison
Buy
83
HBCYF
HSBC Holdings PLC
Last Price:
$9.65
Seasonality Move:
-2.74%
Buy
65
ALGS
Aligos Therapeutics
Last Price:
$41.28
Seasonality Move:
-16.03%
Buy
83
HSBC Holdings PLC (HBCYF)
is a Buy
Is HSBC Holdings PLC a Buy, Sell or Hold?
-
The current HSBC Holdings PLC [HBCYF] share price is $9.55. The Score for HBCYF is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
-
HBCYF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
65
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HBCYF Stock Price Chart
What is HSBC Holdings PLC's stock price today?
-
The HSBC Holdings PLC share price today is $9.55Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HBCYF is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $43.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
HBCYF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 55.45 | Buy |
Chaikin Money Flow: | -2114 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.2 - 9.6) | Buy |
Bollinger Bands (100): | (8.39 - 9.31) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.71 | Buy |
Relative Strength Index (14 RSI): | 81.52 | Buy |
Chaikin Money Flow: | 630913 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.74 - 36.8) | Buy |
Bollinger Bands (100): | (6.83 - 25.23) | Buy |
HBCYF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.57 | Sell |
20-day SMA: | 9.47 | Buy |
50-day SMA: | 9.16 | Buy |
200-day SMA: | 8.62 | Buy |
8-day EMA: | 9.54 | Buy |
20-day EMA: | 9.45 | Buy |
50-day EMA: | 9.22 | Buy |
200-day EMA: | 8.65 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.61 | Buy |
20-day SMA: | 32.22 | Buy |
50-day SMA: | 20.6 | Buy |
200-day SMA: | 16.51 | Buy |
8-day EMA: | 38.12 | Buy |
20-day EMA: | 32.66 | Buy |
50-day EMA: | 24.43 | Buy |
200-day EMA: | 18.11 | Buy |
HSBC Holdings PLC Earnings Growth & HBCYF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
HSBC Holdings PLC Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |